CERAMENT G Device Registry
Recruiting · NCT06010433
Conditions: Chronic Osteomyelitis, Fracture Related Infection, Diabetic Foot Osteomyelitis
At a glance
- Research payments reported, 2025
- $96,902
- U.S. investigators named
- 3
- Sites paid
- 2
- Planned or actual enrollment
- 100
About the trial
- Sponsor
- BONESUPPORT AB
- Tested
- CERAMENT G (device)
- Dates
- Started 2023-08-17; completion 2028-09-22
- Results posted
- Not yet
This is an Observational Device Registry Study of CERAMENT\|G in normal use in accordance with the IFU. It will run for a period of three years from enrolment of the first patient into the Study at each Site, before being subject to review. A Device Registry is a form of observational study that concerns the performance of a device in normal use. It is intended to collect data that is reflective of 'real world' device performance.
From ClinicalTrials.gov, last updated 2025-09-26. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Bone Support Ab reported $96,902 in research payments for this study in 2025 (25 payments).
Products named: Cerament G
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Trent R. Brookshier, DPM Podiatrists · San Diego, CA
- Samuel E. Ford, MD Orthopedic Surgery · Charlotte, NC
- George Ochenjele, M.D. Orthopedic Surgery · Cleveland, OH
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- $69,817
- Orthocarolina Research Institute $24,995
- Uh Cleveland Medical Center, OH $2,090
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.